Odyssey TherapeuticsODTX
13F holders, Q2 2026 (June 30)59holders
3famous investors
$18.71avg. 13F price*
At the end of Q2 2026, 59 institutions reported holding Odyssey Therapeutics Inc. (ODTX) in their 13F filings. The largest holders were FMR LLC ($96.9M), SR One Capital Management, LP ($71.0M) and TPG GP A, LLC ($69.0M). 3 famous investors held it, including Paul Tudor Jones (0.0% of Tudor Investment Corporation's portfolio), Ken Griffin (0.0% of Citadel Advisors's portfolio) and David E. Shaw (0.0% of D. E. Shaw & Co.'s portfolio).
- Company
- Odyssey Therapeutics Inc.
- CUSIP
- 67613T104
- Latest filing quarter
- Q2 2026
Total Exit/New Position Q2 2026
| Institutions | Total Value | |
|---|---|---|
| New Positions | 59 | $652.9M |
| Exits | 0 | $0 |
Ownership 59 holders
| FMR LLC | 0.00% | New | 5,179,262 | $96.9M |
| SR One Capital Management, LP | 6.83% | New | 3,794,883 | $71.0M |
| TPG GP A, LLC | 1.48% | New | 3,690,146 | $69.0M |
| Lightspeed Management Company, L.L.C. | 2.81% | New | 3,608,443 | $67.5M |
| Orbimed Advisors LLC | 1.07% | New | 3,001,198 | $56.2M |
| Sanofi | 6.98% | New | 1,991,918 | $37.3M |
| Deerfield Management Company, L.P. | 0.24% | New | 1,046,139 | $19.6M |
| Sands Capital Alternatives, LLC | 2.67% | New | 875,000 | $16.4M |
| HHLR Advisors, LTD. | 1.87% | New | 831,656 | $15.6M |
| General Catalyst Group Management, LLC | 8.04% | New | 810,272 | $15.2M |
| Affinity Asset Advisors, LLC | 0.71% | New | 766,346 | $14.3M |
| Adage Capital Partners Gp, L.L.C. | 0.02% | New | 725,000 | $13.6M |
| Vanguard Capital Management LLC | 0.00% | New | 720,440 | $13.5M |
| Foresite Capital Management V, LLC | 3.68% | New | 713,105 | $13.3M |
| Vivo Capital, LLC | 0.98% | New | 575,000 | $10.8M |
| EcoR1 Capital, LLC | 0.52% | New | 555,555 | $10.4M |
| Logos Global Management LP | 0.42% | New | 521,736 | $9.8M |
| Marshall Wace, LLP | 0.01% | New | 492,697 | $9.2M |
| T. Rowe Price Associates Inc. | 0.00% | New | 471,987 | $8.8M |
| Catalio Capital Management, LP | 1.61% | New | 457,839 | $8.6M |
| Redmile Group, LLC | 0.53% | New | 425,000 | $8.0M |
| Balyasny Asset Management L.P. | 0.01% | New | 393,862 | $7.4M |
| Woodline Partners LP | 0.02% | New | 345,746 | $6.5M |
| Franklin Resources Inc. | 0.00% | New | 275,022 | $5.1M |
| Boxer Capital Management, LLC | 0.39% | New | 275,000 | $5.1M |
| BlackRock, Inc. | 0.00% | New | 240,679 | $4.5M |
| Citadel Advisors | 0.00% | New | 222,450 | $4.2M |
| Siren, L.L.C. | 0.08% | New | 200,000 | $3.7M |
| Geode Capital Management, LLC | 0.00% | New | 189,488 | $3.5M |
| Cormorant Asset Management, LP | 0.17% | New | 175,000 | $3.3M |
| Aberdeen Group plc | 0.00% | New | 165,000 | $3.1M |
| Two Sigma Investments, LP | 0.00% | New | 156,602 | $2.9M |
| Goldman Sachs Group Inc. | 0.00% | New | 132,801 | $2.5M |
| Charles Schwab Investment Management Inc. | 0.00% | New | 101,531 | $1.9M |
| Vanguard Fiduciary Trust Co. | 0.00% | New | 100,905 | $1.9M |
| State Street Corp. | 0.00% | New | 78,950 | $1.5M |
| Hudson Bay Capital Management LP | 0.01% | New | 72,918 | $1.4M |
| UBS Group AG | 0.00% | New | 68,758 | $1.3M |
| Ensign Peak Advisors, Inc | 0.00% | New | 64,621 | $1.2M |
| Seven Grand Managers, LLC | 0.04% | New | 50,000 | $936K |
| Eversept Partners, LP | 0.05% | New | 49,658 | $929K |
| Tudor Investment Corporation | 0.00% | New | 44,171 | $826K |
| Northern Trust Corp. | 0.00% | New | 34,588 | $647K |
| Manufacturers Life Insurance Company, The | 0.00% | New | 32,125 | $601K |
| TD Asset Management Inc | 0.00% | New | 29,134 | $545K |
| JPMorgan Chase & Co. | 0.00% | New | 27,787 | $525K |
| Ghisallo Capital Management LLC | 0.01% | New | 25,000 | $468K |
| Burkehill Global Management, LP | 0.01% | New | 20,000 | $374K |
| D. E. Shaw & Co. | 0.00% | New | 19,848 | $371K |
| XTX Topco Ltd | 0.00% | New | 16,552 | $310K |
| Vanguard Portfolio Management LLC | 0.00% | New | 13,685 | $256K |
| Vanguard Global Advisers, LLC | 0.00% | New | 7,948 | $149K |
| Omega Fund Management, LLC | 0.03% | New | 2,893 | $54K |
| Legal & General Group Plc | 0.00% | New | 2,000 | $37K |
| Wells Fargo & Company | 0.00% | New | 1,795 | $34K |
| Morgan Stanley | 0.00% | New | 1,772 | $33K |
| Barclays PLC | 0.00% | New | 1,459 | $27K |
| Citigroup Inc. | 0.00% | New | 511 | $10K |
| Tower Research Capital LLC (TRC) | 0.00% | New | 193 | $4K |
"% of holder's portfolio" is ODTX's weight in each manager's 13F, not the share of Odyssey Therapeutics Inc. the manager owns.